2-amino-5-phosphonovalerate has been researched along with Craniocerebral Injuries in 1 studies
2-Amino-5-phosphonovalerate: The D-enantiomer is a potent and specific antagonist of NMDA glutamate receptors (RECEPTORS, N-METHYL-D-ASPARTATE). The L form is inactive at NMDA receptors but may affect the AP4 (2-amino-4-phosphonobutyrate; APB) excitatory amino acid receptors.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Santhakumar, V | 1 |
| Bender, R | 1 |
| Frotscher, M | 1 |
| Ross, ST | 1 |
| Hollrigel, GS | 1 |
| Toth, Z | 1 |
| Soltesz, I | 1 |
1 other study available for 2-amino-5-phosphonovalerate and Craniocerebral Injuries
| Article | Year |
|---|---|
Granule cell hyperexcitability in the early post-traumatic rat dentate gyrus: the 'irritable mossy cell' hypothesis.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Action Potentials; Animals; Bicuc | 2000 |